Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

As a player in the growing telehealth sector, Hims & Hers Health ($HIMS) has grown significantly, driving its stock up over ...

If you’re dealing with male pattern baldness, there’s a good chance you’ve heard of or use finasteride. You also may have ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Market-beating returns could be on the way for patient investors in these two up-and-coming healthcare growth stocks.

After starting it in February, I noticed regrowth around the temples by June and thicker, stronger hair overall by August.” ...

Hims & Hers is a fantastic value despite its high 'on-the-surface' P/E ratio and valuation metrics. The company's subscription-based model in healthcare, targeting chronic conditions, ensures ...

We recently compiled a list of the 10 Best Hair Care Stocks To Buy Now. In this article, we are going to take a look at where Hims & Hers Health ... and hair loss, which will likely lead to ...

We recently compiled a list of the 10 Best Hair Care Stocks To Buy Now. In this article, we are going to take a look at where ...

While symptoms may gradually resolve with a lower dosage, there is no true treatment for medication-related hair loss other than discontinuing the drug. However, don’t stop taking your medication ...

This regrowth treatment is formulated with 5 percent ... Why wait to finally get a handle on your hair loss? With Hims, the solution is just a few clicks away.